ISOPRENE PHARMACEUTICALS INC
BALTIMORE, United States · Founded 2021 · $2.0M raised
- Headquarters
- BALTIMORE, Maryland
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2G
- Total Funding
- $2.0M
- Last Round
- $2.0M GrantJan 2021
- Rounds
- 1
About
Isoprene Pharmaceuticals is an early-stage small molecule oncology company developing oral therapeutics for triple negative breast cancer and other cancers. The company is focused on novel Mnk1/2 protein degraders developed at the University of Maryland Baltimore. It is a spinout of the UMB New Ventures Initiative located at the University of Maryland BioPark. The company received a $2M NCI SBIR grant to advance pre-clinical studies toward an IND filing.
Summary
ISOPRENE PHARMACEUTICALS INC is a Biotech company based in BALTIMORE, United States, founded in 2021. It has raised $2.0M in total across 1 round, most recently a $2.0M Grant round in Jan 2021. Investors include National Cancer Institute.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2021
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...